Not checked for notices yet.
Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes
Kwong-Man Ng, Yee-Man Lau, Vidhu Dhandhania and 5 more
Scientific Reports · 2018
doi:10.1038/s41598-018-33293-2
Cited by papers we hold 3
- Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure · 2021Corrected
- The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin · 2021No notice
- Patient and Disease–Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics · 2020No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.